getmoreshares Tuesday, 06/23/20 04:13:20 PM Re: None Post # of 148328 FYI: DSUS - Angella Collette did some custodianship filing for that one over a year ago in Michigan (despite it being a NV entity) then reinstated the entity in Nevada on 9/17/19. I haven't followed it much since then, but I see that she dissolved the Nevada entity on 3/24/20 and moved it to Wyoming. Obvious the pop today is because the name of the shell was changed to China Eastern Shengda Biotechnology Corporation at the Wyoming SOS today, new value was assigned to the preferred stock, and Fu Li is now listed as the new president of the entity (presumably because control of the shell has been sold to Fu Li). Only details for Fu Li are a phone number in China at 011-86-16602127860 and an email at firstname.lastname@example.org The email links to some old Chinese entity named Shanghai Jiali Asset Management Center. https://xin.baidu.com/company_detail_32263013603168 (Could not translate the link) There are several "Shengda Biotechnology" companies in China, but I see no proof that that any of them link to Fu Li. One big thing people need to watch out for is that the A/S was lowered from 20,000,000,000 to 400,000,000. This could mean a 1:50 reverse split is in the works. But the old A/S was 400,000,000 before it was moved to Wyoming so it's hard to say for sure. Plus there is no guarantee that FINrA will approve a reverse split on the shell even if that is the plan. courtesy of "nodummy"